RCUS
Arcus Biosciences, Inc.Healthcare$22.96
▲ Bullish
Mkt Cap: $2.88B|Float: 88.7M|SI: 9.7%|DTC: 6.5
Data as of market close Apr 2, 2026
IV Rank
77
IV Pctl
78%
HV 20d
62.4%
52W Range
$7-$26
ATR(14)
$1.16
Exp. Move
±11.1%
P/C Ratio
0.25
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
RCUS Key Options Data
- IV Rank
- 77.3%
- Total GEX
- $0.00B
- Total DEX
- $0.6M
- Max Pain
- $15.00
- Expected Move
- ±11.1%
- Put/Call OI
- 0.25
- Net Premium
- $0.2M
- Spot Price
- $22.96
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.55 | ±11.1% | $20.41 | $25.51 |
| 2026-06-18 | 77 | ±$7.08 | ±30.8% | $15.88 | $30.03 |
| 2026-07-17 | 106 | ±$4.30 | ±18.7% | $18.66 | $27.26 |
| 2026-10-16 | 197 | ±$6.20 | ±27.0% | $16.76 | $29.16 |
| 2026-12-18 | 260 | ±$13.05 | ±56.8% | $9.91 | $36.01 |
| 2027-01-15 | 288 | ±$7.00 | ±30.5% | $15.96 | $29.96 |
Explore RCUS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.